Cargando…

Development of potential COVID-19 vaccines continues to accelerate

Detalles Bibliográficos
Autor principal:	Kirby, Tony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333995/ https://www.ncbi.nlm.nih.gov/pubmed/32835342 http://dx.doi.org/10.1016/S2666-5247(20)30070-7

Ejemplares similares

Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
por: Bok, Karin, et al.
Publicado: (2021)

Safety surveillance and challenges in accelerated COVID-19 vaccine development
por: Cole, Abimbola, et al.
Publicado: (2022)

Accelerated Development of COVID-19 Vaccines: Technology Platforms, Benefits, and Associated Risks
por: Wagner, Ralf, et al.
Publicado: (2021)

The quest continues for perfect COVID-19 vaccine
por: Bhatia, Rajesh
Publicado: (2021)

South America prepares for the impact of COVID-19
por: Kirby, Tony
Publicado: (2020)

UK senior police officer with COVID-19
por: Kirby, Tony
Publicado: (2020)

COVID-19 human challenge studies in the UK
por: Kirby, Tony
Publicado: (2020)

Kanta Subbarao—confronting influenza and COVID-19
por: Kirby, Tony
Publicado: (2022)

Alemka Markotić—from hantavirus to COVID-19
por: Kirby, Tony
Publicado: (2023)

COVID-19 survivor experiencing long-term symptoms
por: Kirby, Tony
Publicado: (2021)

Global tuberculosis progress reversed by COVID-19 pandemic
por: Kirby, Tony
Publicado: (2021)

Paul Harrison—investigating the psychiatric sequelae of COVID-19
por: Kirby, Tony
Publicado: (2022)

UK HIV transmission drops in the wake of COVID-19
por: Kirby, Tony
Publicado: (2023)

Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities
por: Kirby, Tony
Publicado: (2020)

Patient collaboration in COVID-19 research: translating ideas to reality
por: Kirby, Tony
Publicado: (2023)

Analysis of the COVID-19 Vaccine Development Process: an Exploratory Study of Accelerating Factors and Innovative Environments
por: Defendi, Hugo Garcia Tonioli, et al.
Publicado: (2021)

Rheumatologists rapidly adjust patient care during COVID-19 pandemic
por: Kirby, Tony
Publicado: (2020)

Efforts escalate to protect homeless people from COVID-19 in UK
por: Kirby, Tony
Publicado: (2020)

Accélérer la vaccination contre la Covid-19()()
Publicado: (2021)

Accelerated waning of the humoral response to COVID-19 vaccines in obesity
por: van der Klaauw, Agatha A., et al.
Publicado: (2023)

New variant of SARS-CoV-2 in UK causes surge of COVID-19
por: Kirby, Tony
Publicado: (2021)

Feng-Cai Zhu: leading vaccine evaluation in China
por: Kirby, Tony
Publicado: (2015)

MMR vaccination in England falls below critical threshold
por: Kirby, Tony
Publicado: (2022)

Philip Morris ejected from Canadian vaccine collaboration
por: Kirby, Tony
Publicado: (2023)

Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID‐19 vaccines in Europe
por: Wagner, Ralf, et al.
Publicado: (2021)

COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development
por: Vo, Giau Van, et al.
Publicado: (2022)

The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues
por: Gong, Wenping, et al.
Publicado: (2022)

Accelerated national lot release on COVID-19 vaccines in Republic of Korea
por: Yang, Misook, et al.
Publicado: (2022)

The Race for COVID-19 Vaccines: Accelerating Innovation, Fair Allocation and Distribution
por: Daems, Rutger, et al.
Publicado: (2022)

Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine
por: Thiel, Natalie, et al.
Publicado: (2021)

Continuous, hyperfractionated, accelerated radiotherapy (CHART).
por: Dische, S., et al.
Publicado: (1989)

The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development
por: Roordink, Danielle, et al.
Publicado: (2021)

EMA and ICMRA urge continuation of COVID-19 vaccine safety trials
Publicado: (2020)

Why does COVID-19 continue to spread despite mass vaccination?
por: Zhang, Shuo, et al.
Publicado: (2022)

Heterologous COVID-19 vaccination as a strategy to accelerate mass immunization
por: Klastrup, Vibeke, et al.
Publicado: (2022)

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations
por: Niyomnaitham, Suvimol, et al.
Publicado: (2023)

Lessons from the COVID-19 pandemic for accelerating sustainable development
por: Tonne, Cathryn
Publicado: (2021)

The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development Efforts
por: Khan, Israr, et al.
Publicado: (2020)

COMMITMENT AND CALL TO ACTION: GLOBAL COLLABORATION TO ACCELERATE NEW COVID-19 HEALTH TECHNOLOGIES: A Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines
Publicado: (2020)

Ensuring continued progress for development of COVID-19 therapeutics in children
por: Noel, Gary J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vfpi6euncalpo2g5v4pvmfincp